Mirati Therapeutics, Inc.
MRTXDelisted- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001576263
Mirati Therapeutics, Inc. was delisted in 2024; its insiders filed their last Form 4 on Jan 25, 2024; 218 institutions reported holding it in 13F filings for Q4 2023, worth $5.03B in total; no superinvestor held it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Mirati Therapeutics, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Mirati Therapeutics, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Lewis Joseph | Other: See remarks | 0Indirect | Jan 25, 2024 | 0 |
| Fuglesang Christopher | Other: See remarks | 0Indirect | Jan 25, 2024 | 0 |
| Boxer Asset Management Inc. | Other: See remarks | 0Indirect | Jan 25, 2024 | 0 |
| Boxer Capital, LLC | Other: See remarks | 0Indirect | Jan 25, 2024 | 0 |
| Davis Aaron I. | Other: See remarks | 0Indirect | Jan 25, 2024 | 0 |
| MVA Investors, LLC | Other: See remarks | 0Indirect | Jan 25, 2024 | 0 |
| Braslyn Ltd. | Other: See remarks | 0Indirect | Jan 25, 2024 | 0 |
| Dissanayake Shehan Bharatha | Other: See remarks | 0Indirect | Jan 25, 2024 | 0 |
| Lockend Five, LLC | Other: See remarks | 0Indirect | Jan 25, 2024 | 0 |
| Carter Bruce L A | Director | 0 | Jan 23, 2024 | 0 |
| Gallagher Carol Giltner | Director | 0 | Jan 23, 2024 | 0 |
| Hasnain Faheem | Director | 0 | Jan 23, 2024 | 0 |
| Johnson Craig A | Director | 0 | Jan 23, 2024 | 0 |
| Sharp Shalini | Director | 0 | Jan 23, 2024 | 0 |
| Moriarty John B | Chief Legal Officer | 0 | Jan 23, 2024 | 0 |
| Baum Charles M | Founder, President, and CEO | 0 | Jan 23, 2024 | 0 |
| Christensen Jamie | EVP & Chief Scientific Officer | 0 | Jan 23, 2024 | 0 |
| Hickey Benjamin | EVP, Chief Commercial Officer | 0 | Jan 23, 2024 | 0 |
| Martinez Maria E | Director | 0 | Jan 23, 2024 | 0 |
| Cherrington Julie M | Director | 0 | Jan 23, 2024 | 0 |
| Sandler Alan B. | Chief Medical Officer | 0 | Jan 23, 2024 | 0 |
| Ondrey Aaron | Chief Financial Officer | 0 | Jan 23, 2024 | 0 |
| Stelzer Laurie | Chief Financial Officer | 102,312 | Aug 10, 2023 | 0 |
| Fuchs Henry J | Director | 10,465 | Jan 24, 2023 | 0 |
| Meek David D. | Chief Executive Officer | 151,171 | Jan 24, 2023 | 0 |
| Reed Vickie S | SVP, Chief Accounting Officer | 15,369 | Jan 18, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 18, 2024 (view filing) | Jan 16 | 2 days | Hickey BenjaminEVP, Chief Commercial Officer | SSale | −1.60K | $59.02 | −$94.3K | −1.3%117.0K after | 2 lots |
| Jan 18, 2024 (view filing) | Jan 16 | 2 days | Christensen JamieEVP & Chief Scientific Officer | SSale | −1.60K | $59.02 | −$94.3K | −1.0%155.9K after | 2 lots |
| Jan 9, 2024 (view filing) | Jan 8 | 1 day | Hickey BenjaminEVP, Chief Commercial Officer | SSale | −2.09K | $58.92 | −$123.1K | −1.7%118.6K after | |
| Jan 5, 2024 (view filing) | Jan 4 | 1 day | Christensen JamieEVP & Chief Scientific Officer | SSale | −1.53K | $58.81 | −$90.0K | −1.0%157.1K after | |
| Dec 19, 2023 (view filing) | Dec 18 | 1 day | Christensen JamieEVP & Chief Scientific Officer | SSale | −2.39K | $57.50 | −$137.3K | −1.7%141.6K after | |
| Dec 14, 2023 (view filing) | Dec 13 | 1 day | Hickey BenjaminEVP, Chief Commercial Officer | SSale | −2.22K | $56.67 | −$125.8K | −2.1%103.7K after | |
| Sep 12, 2023 (view filing) | Sep 8 | 4 days | Christensen JamieEVP & Chief Scientific Officer | SSale | −2.39K | $35.63 | −$85.1K | −1.6%144.0K after | |
| Aug 15, 2023 (view filing)9:39 PM ET | Aug 11 | 4 days | Lewis Joseph and 6 othersOther: See remarks | PPurchase | +57.5K | $27.80 | +$1.60M | +25.0%287.9K after | Duplicate filing |
| Aug 15, 2023 (view filing)9:39 PM ET | Aug 11 | 4 days | Lewis Joseph and 6 othersOther: See remarks | PPurchase | +1.20M | $27.80 | +$33.4M | +60.1%3.20M after | Duplicate filing |
| Aug 15, 2023 (view filing)9:38 PM ET | Aug 11 | 4 days | Lewis Joseph and 6 othersOther: See remarks | PPurchase | +57.5K | $27.80 | +$1.60M | +25.0%287.9K after | |
| Aug 15, 2023 (view filing)9:38 PM ET | Aug 11 | 4 days | Lewis Joseph and 6 othersOther: See remarks | PPurchase | +1.20M | $27.80 | +$33.4M | +60.1%3.20M after | |
| Aug 14, 2023 (view filing) | Aug 11 | 3 days | Hasnain FaheemDirector | PPurchase | +10.8K | $27.80 | +$300.0K | New position10.8K after | |
| Jun 2, 2023 (view filing) | Jun 2 | Same day | Stelzer LaurieChief Financial Officer | SSale | −4.65K | $37.06 | −$172.2K | −5.5%80.0K after | |
| May 24, 2023 (view filing) | May 24 | Same day | Christensen JamieEVP & Chief Scientific Officer | SSale | −619 | $45.29 | −$28.0K | −0.5%124.1K after | |
| Jan 20, 2023 (view filing) | Jan 18 | 2 days | Cherrington Julie MDirector | SSale | −2.55K | $44.66 | −$113.7K | −100.0%0 after | |
| Jan 19, 2023 (view filing) | Jan 17 | 2 days | Meek David D.Chief Executive Officer | SSale | −3.18K | $42.38 | −$134.7K | −4.9%61.8K after | |
| Jan 19, 2023 (view filing) | Jan 17 | 2 days | Christensen JamieEVP, Chief Scientific Officer | SSale | −2.25K | $42.38 | −$95.1K | −2.2%97.9K after | 2 lots |
| Jan 19, 2023 (view filing) | Jan 17 | 2 days | Hickey BenjaminEVP, Chief Commercial Officer | SSale | −1.57K | $42.38 | −$66.4K | −3.2%47.2K after | 2 lots |
| Jan 10, 2023 (view filing) | Jan 9 | 1 day | Hickey BenjaminEVP, Chief Commercial Officer | SSale | −2.09K | $45.37 | −$94.7K | −4.1%48.8K after | |
| Jan 5, 2023 (view filing) | Jan 4 | 1 day | Baum Charles MPresident,Founder,Head of R&D | SSale | −3.65K | $46.60 | −$170.0K | −2.1%168.8K after | |
| Jan 5, 2023 (view filing) | Jan 4 | 1 day | Christensen JamieEVP, Chief Scientific Officer | SSale | −1.95K | $46.60 | −$90.8K | −1.9%100.1K after | |
| Dec 21, 2022 (view filing) | Dec 21 | Same day | Baum Charles MPresident,Founder,Head of R&D | SSale | −9.09K | $40.42 | −$367.5K | −5.0%172.4K after | |
| Dec 21, 2022 (view filing) | Dec 21 | Same day | Hickey BenjaminEVP, Chief Commercial Officer | SSale | −3.25K | $40.41 | −$131.3K | −6.0%50.9K after | |
| Dec 21, 2022 (view filing) | Dec 21 | Same day | Meek David D.Chief Executive Officer | SSale | −4.62K | $40.41 | −$186.5K | −6.6%65.0K after | |
| Dec 20, 2022 (view filing) | Dec 16 | 4 days | Christensen JamieEVP, Chief Scientific Officer | SSale | −2.41K | $43.00 | −$103.6K | −2.3%102.1K after | |
| Dec 5, 2022 (view filing) | Dec 2 | 3 days | Christensen JamieEVP, Chief Scientific Officer | SSale | −1.73K | $90.19 | −$155.7K | −1.6%104.5K after | |
| Nov 28, 2022 (view filing) | Nov 28 | Same day | Baum Charles MPresident,Founder,Head of R&D | SSale | −69.3K | $100.00 | −$6.93M | −35.1%127.9K after | |
| Aug 16, 2022 (view filing) | Aug 12 | 4 days | Carter Bruce L ADirector | SSale | −10.0K | $85.49 | −$854.9K | −62.4%6.02K after | 2 lots |
| Jun 14, 2022 (view filing) | May 23 | 22 daysLate | Christensen JamieEVP, Chief Scientific Officer | SSale | −624 | $63.54 | −$39.6K | −0.7%86.8K after | |
| Feb 14, 2022 (view filing) | Feb 11 | 3 days | Fuchs Henry JDirector | SSale | −11.0K | $105.61 | −$1.16M | −64.6%6.02K after | 3 lots |
| Jan 20, 2022 (view filing) | Jan 19 | 1 day | Cherrington Julie MDirector | SSale | −1.48K | $116.07 | −$171.2K | −36.7%2.55K after | |
| Jan 18, 2022 (view filing) | Jan 18 | Same day | Reed Vickie SSVP, Chief Accounting Officer | SSale | −533 | $120.48 | −$64.2K | −3.4%15.4K after | |
| Jan 18, 2022 (view filing) | Jan 18 | Same day | Christensen JamieEVP, Chief Scientific Officer | SSale | −627 | $120.51 | −$75.6K | −0.7%87.4K after | |
| Jan 18, 2022 (view filing) | Jan 18 | Same day | Baum Charles MPresident,Founder,Head of R&D | SSale | −2.52K | $120.48 | −$303.2K | −1.9%127.9K after | |
| Jan 18, 2022 (view filing) | Jan 18 | Same day | Hickey BenjaminEVP, Chief Commercial Officer | SSale | −627 | $120.48 | −$75.5K | −1.8%35.0K after | |
| Jan 7, 2022 (view filing) | Jan 7 | Same day | Hickey BenjaminEVP, Chief Commercial Officer | SSale | −1.96K | $135.94 | −$267.0K | −7.3%24.8K after | |
| Jan 7, 2022 (view filing) | Jan 7 | Same day | Reed Vickie SSVP, Chief Accounting Officer | SSale | −345 | $135.94 | −$46.9K | −3.2%10.5K after | |
| Jan 6, 2022 (view filing) | Jan 4 | 2 days | Baum Charles MPresident,Founder,Head of R&D | SSale | −4.11K | $147.75 | −$607.9K | −3.9%101.2K after | 2 lots |
| Jan 6, 2022 (view filing) | Jan 4 | 2 days | Christensen JamieEVP, Chief Scientific Officer | SSale | −1.44K | $147.72 | −$213.0K | −1.8%77.3K after | |
| Jan 6, 2022 (view filing) | Jan 4 | 2 days | Reed Vickie SSVP, Chief Accounting Officer | SSale | −758 | $147.74 | −$112.0K | −6.5%10.9K after | |
| Dec 7, 2021 (view filing) | Dec 6 | 1 day | Christensen JamieEVP, Chief Scientific Officer | SSale | −1.20K | $130.79 | −$157.1K | −2.0%59.5K after | 2 lots |
| Dec 3, 2021 (view filing) | Dec 3 | Same day | Baum Charles MPresident & Head of R&D | SSale | −47.2K | $133.20 | −$6.29M | −29.5%112.7K after | 7 lots |